Showing posts with label Culture in HAT media. Show all posts
Showing posts with label Culture in HAT media. Show all posts

Thursday, January 6, 2011

Culture in HAT media

Culture in HAT media
  • Unfused myeloma cells (HGPRT-) die out because they cannot make purines.
  • Unfused spleen cells (containing B-cells) die out because they have a limited life span
  • The only cells that will survive are the fused B-cell: myeloma cells = hybridomas
2. Test fused cells for antibodies by ELIZA
3. Subculture and clone positives.
4. Test supernatants for antibodies
5. "Expand' or scale up the best clone
(all derived from a single cell = monoclonal)
6. Hybridoma cultures producing monoclonal antibodies can be maintained indefinitely in vitro or in vivo
7. MAbs can be developed into drugs, and injected into a person to seek out, bind, and target for destruction the antigen against which the antibody was raised.

The combination of antibody specificity (B cell) + unlimited proliferation (myeloma):

Because the human body eventually develops an immune response against the monoclonal antibody (made from a mouse B-cell), most monoclonal antibody-based drugs today are so-called humanized monoclonal antibodies: the mouse antibody is carefully digested to release just the antigen-binding variable region, which is then swapped into a human antibody missing its variable region. This prevents an immune response to the antibody itself.

A fully humanized monoclonal antibody has the antigen binding murine complementarity-determining regions interspersed within the variable regions of the light (light gray) and heavy (dark gray) chains of the Fab portion of the engineered antibody. A chimeric antibody has the entire antigen-binding murine component of the variable region of the Fab section is maintained integrally (handout).